VATHAROGA CHOORANAM for Cervical Spondylosis

PHASE II NON RANDOMIZED OPEN CLINICAL EVALUATION OF SIDDHA MEDICINE VATHAROGA CHOORANAM FOR THE MANAGEMENT OF SAGANAVATHAM (CERVICAL SPONDYLOSIS) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/060321

Enrollment

Registered

2023-11-29

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy

Interventions

Intervention1: VATHAROGA CHOORANAM: The Siddha drug will be given as 1500mg BD dose with Honey,for 48 days for the management of Cervical Spondylosis. Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Neck pain radiating to upper limb with or without numbness,giddiness and neck stiffness. Shoulder abduction pain relief sign -positive Lhermittes and spurlings sign - positive

Exclusion criteria

Exclusion criteria: Known case of Ankylosing spondylitis Adhesive capsulitis Traumatic injury Extra cervical rib Congenital spinal anomalies Tuberculosis of spine Secondary malignancy Ischemic heart disease Type II Diabetes Mellitus chronic kidney disease Pregnant women and lactating mothers

Design outcomes

Primary

Measure	Time frame
Reduction in clincal symptoms such as neck pain radiating to upper limb,numbness,neck stiffness.Timepoint: 3 WEEKS	—

Secondary

Measure	Time frame
VISUAL ANALOGUE SCALETimepoint: 7 WEEKS	—

Countries

India

Contacts

Public ContactSathya Nandini T

Government Siddha Medical College, Chennai

mmsankar2000@gmail.com9445716802

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026